(Q30424857)

10 August 2017

Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial (English)

1 reference

10 August 2017

10

Steven A Kaplan

1 reference

10 August 2017

6

J Curtis Nickel

1 reference

10 August 2017

15

John W Kusek

1 reference

10 August 2017

7

Claus G Roehrborn

1 reference

10 August 2017

12

Gerald L Andriole

1 reference

10 August 2017

19

Kevin T McVary

1 reference

10 August 2017

Michael J Barry

1

1 reference

10 August 2017

Sreelatha Meleth

2

1 reference

10 August 2017

Jeannette Y Lee

3

1 reference

10 August 2017

Karl J Kreder

4

1 reference

10 August 2017

Andrew L Avins

5

1 reference

10 August 2017

E David Crawford

8

1 reference

10 August 2017

Harris E Foster

9

1 reference

10 August 2017

Andrew McCullough

11

1 reference

10 August 2017

Michael J Naslund

13

1 reference

10 August 2017

O Dale Williams

14

1 reference

10 August 2017

Catherine M Meyers

16

1 reference

10 August 2017

Joseph M Betz

17

1 reference

10 August 2017

Alan Cantor

18

1 reference

10 August 2017

Complementary and Alternative Medicine for Urological Symptoms (CAMUS) Study Group

20

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 September 2011

1 reference

The Journal of the American Medical Association

10 August 2017

1 reference

10 August 2017

306

1 reference

10 August 2017

12

1 reference

10 August 2017

1344-1351

1 reference

Recruitment of participants to a clinical trial of botanical therapy for benign prostatic hyperplasia

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5alpha-reductase II.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

Serenoa repens for benign prostatic hyperplasia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

Complementary and alternative medicine use among adults and children: United States, 2007

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

A detailed safety assessment of a saw palmetto extract

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

Development and validation of four-item version of Male Sexual Health Questionnaire to assess ejaculatory dysfunction

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

Saw palmetto for benign prostatic hyperplasia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

Serenoa repens for benign prostatic hyperplasia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

Scoring the short form ICSmaleSF questionnaire. International Continence Society

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

Saw palmetto for the treatment of men with lower urinary tract symptoms

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of The American Urological Association.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

New diagnostic and treatment guidelines for benign prostatic hyperplasia. Potential impact in the United States

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

A scale for the estimation of sleep problems in clinical research

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

The ethics of sample size: two-sided testing and one-sided thinking

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326341

Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21954478

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1001/JAMA.2011.1364

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

21954478

1 reference